跳至主要内容
临床试验/ACTRN12612000710820
ACTRN12612000710820尚未招募4 期

ovel Interventions in Heart Failure with Preserved Ejection Fraction -a single centre, randomised double blinded placebo cross-over pilot study using IVABRADINE, to assess the effect on 6 minute walk test, peak oxygen consumption and New York heart association Class of symptoms, from the Flinders Clinical Research group, Flinders University.

South Australian Health and Medical Research Institute0 个研究点目标入组 20 人开始时间: 2012年7月3日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Age greater than or equal to 18 years
  • HF-PEF (LVEF greater than or equal to 50% within 6m of randomisation)
  • NYHA II-III
  • Diastolic dysfunction on echo
  • E/A equal to 1, E/E’ equal to or greater than 15, deceleration time less than or equal to 140ms
  • Heart rate over 70/min
  • Stable disease, confirmed by no hospital admissions or HF medication changes within 3m prior to randomisation
  • Informed consent
  • No other causes for exertional dyspnoea

排除标准

  • Atrial Fibrillation
  • Contraindications to MRI
  • Significant valvular or coronary disease as primary cause of HF
  • Hypertrophic cardiomyopathy, cardiac amyloidosis, sarcoidosis
  • GFR equal to or greater than 45 ml/min

研究者

相似试验